Urinary excretion of deprenyl metabolites

Journal of Chromatography A

Volumn 762, Issue 1-2, 1997, Pages 321-326

  Lengyel, József ^a   Magyar, Kálmán ^a   Hollósi, Ildikó ^b   Bartók, Tibor ^c   Báthori, Mária ^d   Kalász, Huba ^a   Fürst, Susanna ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b National Institute of Environmental   (Hungary)

^c CEREAL RESEARCH NON PROFIT COMPANY   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Amphetamines; Deprenyl metabolites; Enzyme inhibitors

Indexed keywords

AMPHETAMINE; DRUG METABOLITE; METHAMPHETAMINE; SELEGILINE;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG METABOLISM; DRUG URINE LEVEL; ENANTIOMER; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MASS SPECTROMETRY; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THIN LAYER CHROMATOGRAPHY; URINARY EXCRETION;

ANIMALS; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, WISTAR; SELEGILINE;

EID: 0031581878     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9673(97)00009-5     Document Type: Conference Paper

References (28)

1. [1] J. Knoll and K. Magyar, Adv. Biochem. Pharmacol., 5 (1972) 393.
2. [2] J. Knoll, J. Neural. Transm., 43 (1978) 177.
3. [3] The Parkinson study group, N. Engl. J. Med., 321 (1989) 1364.
4. [4] E.H. Heinonen and R. Lammintausta, Acta Neurol. Scand., 8 Suppl. (1991) 44.
5. [5] M.B.H. Youdim, J. Neural Transm., 43 (1978) 199.
6. [6] P.N. Tariot, R.M. Cohen and T. Sunderland, Arch. Gen. Psychiatry, 44 (1987) 427.
7. [7] H. Kalász, L. Kerecsen, J. Knoll and J. Pucsok, J. Chromatogr., 499 (1990) 589.
8. [8] L. Kerecsen, H. Kalász, J. Tarczali, J. Fekete and J. Knoll, in H. Kalász and L.S. Ettre (Editors), Chromatography, the State of the Art, Akadémiai Kiadó, Budapest, 1985, p. 195.
9. [9] Please supply reference.
10. [10] X. Zhang, P.H. Yu, B.A. Davis, C.T. Zuo and A.A. Boulton: Abstracts of the 7th Amine Oxidase Workshop, Shavei Zion, Israel, 1996, p. 70.
11. [11] Y.M. Buys, G.E. Trope and W.G. Tatton, Curr. Eye Res., 14 (1995) 119.
12. [12] G.P. Reynolds, P. Riederer, M. Sandler, K. Jellinger and D. Seeman, J. Neural Transm., 43 (1978) 271.
13. [13] J.D. Elsworth, M. Sandler, A.J. Lees, C. Ward and G.M. Stern, J., J. Neural Transm., 54 (1982) 105.
14. [14] E.H. Heinonen, M.I. Anttila and R.A.S. Lammintausta, Clin. Pharm. Ther., 56 (1994) 742.
15. [15] E.H. Heinonen, V. Myllyla, K. Sotanierni, et. al., Acta Neurol. Scand., 80 (1989) 93.
16. [16] J.E. Meeker and P.C. Reynolds, J. Anal. Toxicol., 14 (1990) 330.
17. [17] M. Schachter, C.D. Marsden, J.D. Parkes, P. Jenner and B. Testa, J. Neurol. Neurosurg. Psychiatry, 43 (1978) 271.
18. [18] T. Yoshida, T. Oguro and Y. Kuroiwa, Xenobiotica, 17 (1987) 957.
19. [19] H. Kalász, J. High Resolut. Chromatogr. Chromatogr. Commun., 6 (1983)49.
20. [20] K. Magyar and L. Tóthfalusi, Pol. J. Pharmacol. Pharm., 36 (1984) 373.
21. [21] J.S. Salonen, J. Chromatogr., 527 (1990) 163.
22. [22] A. Ishigami, K. Takahasi, M. Shimamine, Y. Nakahara and Y. Takeda, J. Hygiene Chem., 36 (1990) 74.
23. [23] G. Szebeni, J. Lengyel, G. Székács, K. Magyar, J. Gaál and I. Szathmári, Acta Physiol. Hung., 83 (1995) 135.
24. [24] R. La Croix, E. Pianezzola and M. Strolin Benedetti, J. Chromatogr. B., 656 (1994) 251.
25. [25] J.M. Grace, M.T. Kinter and T.L. Macdonald, Chem. Res. Toxicol., 7 (1994) 286.
26. [26] É. Szökö and K. Magyar, J. Chromatogr., 709 (1995) 157.
27. [27] É. Szökö and K. Magyar, Int. J. Pharm. Adv., 1 (1996) 320.
28. [28] G.L. Biagi, A.M. Barbaro, A. Sapone and M. Recanatini, J. Chromatogr. A., 662 (1994) 341.